| 1. |
- Bravo, L, et al.
(author)
-
- 2021
-
swepub:Mat__t
|
|
| 2. |
- Tabiri, S, et al.
(author)
-
- 2021
-
swepub:Mat__t
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
- Hellings, P. W., et al.
(author)
-
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
- 2023
-
In: Frontiers in Allergy. - 2673-6101. ; 4
-
Journal article (peer-reviewed)abstract
- In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an evidence-supported platform to introduce innovation and education in healthcare leading to optimal patient care, bridging the gap between latest scientific evidence and daily practice. Aligned with the mission of improving health care, the expert panels of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS) & European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergen immunotherapy (AIT) and paediatrics have proposed and elaborated a variety of activities that correspond to major unmet needs in the allergy and respiratory field. The current report provides a concise overview of the achievements, ambitions, and action plan of EUFOREA for the future, allowing all stakeholders in the allergy and respiratory field to be up-dated and inspired to join forces in Europe and beyond.
|
|
| 8. |
- Vivek, S.S., et al.
(author)
-
Impact and Durability Properties of Alccofine-Based Hybrid Fibre-Reinforced Self-Compacting Concrete
- 2023
-
In: Case Studies in Construction Materials. - : Elsevier. - 2214-5095. ; 19
-
Journal article (peer-reviewed)abstract
- Many research works have already been made and are still in progress on metallic fibres, as their incorporation reduces the brittleness of the concrete and improves its resistance to the impact and crack propagation. But the use of such non-metallic fibres may induce corrosion which is a major problem to be addressed from the durability aspect. To overcome this problem, in the present research work, a non-metallic hybrid fibre combination was investigated with synthetic fibres like polypropylene and abaca fibres. Also, rather than using conventional cementitious materials such as silica fume, fly ash, and ground granulated blast furnace slag, a new generation of ultra-fine material namely alccofine was used as a partial replacement for the cement by 15%. Abaca fibre was utilised in a constant addition of 0.5% and blended with polypropylene fibre in a range varying from 0% to 2% with an increment of 0.5%. The fresh properties of self-compacting concrete (SCC) in mono and hybrid fibres combinations were assessed through slump flow, J-ring, and V-funnel tests. Water absorption and sorptivity tests were conducted to ensure the durability of the prepared mix. Further, impact tests were carried out on the prepared cylinder specimens to check the capability of the mix with the non-metallic hybrid combination. The main objective here was to check whether a high-strength durable SCC could be achieved using non-metallic fibres and natural fibres. From the obtained experimental results, it was observed that 15% alccofine as a partial substitute to the cement with the addition of 0.5% of abaca fibre and 2% of polypropylene fibre to SCC performed better than the control SCC.
|
|
